The following adverse events have been observed to occur in predialysis patients treated with r-HuEPO more frequently than in predialysis patients treated with placebo: Hypertension; headache; arthralgia; pyrexia.
No adverse events have been observed in AIDS patients treated with r-HuEPO more frequently than in AIDS patients treated with placebo.
View ADR Monitoring Form